 | • レポートコード：MRC2012B0505 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ヒト胚性幹細胞アッセイの世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒト胚性幹細胞アッセイの種類別市場規模（生存率・細胞毒性、単離・精製、細胞同定、増殖、分化、機能、アポトーシス）、用途別市場規模（バイオ医薬品・バイオテクノロジー企業、研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、Miltenyi Biotec、Bio-Rad Laboratories、Merck、Perkinelmer、GE Healthcare、Hemogenix、Agilent Technologies、Promega Corporation、Cell Biolabs、Stemcell Technologies、Bio-Techne Corporation、Cellular Dynamics International (CDI)、 ・地域別グローバル市場分析 2015年-2020年 ・ヒト胚性幹細胞アッセイの北米市場（アメリカ、カナダ、メキシコ） ・ヒト胚性幹細胞アッセイのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒト胚性幹細胞アッセイのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒト胚性幹細胞アッセイの南米市場（ブラジル、アルゼンチン） ・ヒト胚性幹細胞アッセイの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生存率・細胞毒性、単離・精製、細胞同定、増殖、分化、機能、アポトーシス ・用途別分析：バイオ医薬品・バイオテクノロジー企業、研究所 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Human Embryonic Stem Cell Assay market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Human Embryonic Stem Cell Assay market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Human Embryonic Stem Cell Assay market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Human Embryonic Stem Cell Assay market has been segmented into:
Viability/Cytotoxicity
Isolation & Purification
Cell Identification
Proliferation
Differentiation
Function
Apoptosis
By Application, Human Embryonic Stem Cell Assay has been segmented into:
Biopharmaceutical & Biotechnology Companies
Research Institutes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Embryonic Stem Cell Assay market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Embryonic Stem Cell Assay markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Embryonic Stem Cell Assay market.
The report offers in-depth assessment of the growth and other aspects of the Human Embryonic Stem Cell Assay market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Human Embryonic Stem Cell Assay Market Share Analysis
Human Embryonic Stem Cell Assay competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Embryonic Stem Cell Assay sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Embryonic Stem Cell Assay sales, revenue and market share for each player covered in this report.
The major players covered in Human Embryonic Stem Cell Assay are:
Thermo Fisher Scientific
Miltenyi Biotec
Bio-Rad Laboratories
Merck
Perkinelmer
GE Healthcare
Hemogenix
Agilent Technologies
Promega Corporation
Cell Biolabs
Stemcell Technologies
Bio-Techne Corporation
Cellular Dynamics International (CDI)
Table of Contents
1 Human Embryonic Stem Cell Assay Market Overview
1.1 Product Overview and Scope of Human Embryonic Stem Cell Assay
1.2 Classification of Human Embryonic Stem Cell Assay by Type
1.2.1 Global Human Embryonic Stem Cell Assay Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Human Embryonic Stem Cell Assay Revenue Market Share by Type in 2019
1.2.3 Viability/Cytotoxicity
1.2.4 Isolation & Purification
1.2.5 Cell Identification
1.2.6 Proliferation
1.2.7 Differentiation
1.2.8 Function
1.2.9 Apoptosis
1.3 Global Human Embryonic Stem Cell Assay Market by Application
1.3.1 Overview: Global Human Embryonic Stem Cell Assay Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biopharmaceutical & Biotechnology Companies
1.3.3 Research Institutes
1.4 Global Human Embryonic Stem Cell Assay Market by Regions
1.4.1 Global Human Embryonic Stem Cell Assay Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Human Embryonic Stem Cell Assay (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Human Embryonic Stem Cell Assay Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Human Embryonic Stem Cell Assay Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Embryonic Stem Cell Assay Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Human Embryonic Stem Cell Assay Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Embryonic Stem Cell Assay Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.2 Miltenyi Biotec
2.2.1 Miltenyi Biotec Details
2.2.2 Miltenyi Biotec Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Miltenyi Biotec SWOT Analysis
2.2.4 Miltenyi Biotec Product and Services
2.2.5 Miltenyi Biotec Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bio-Rad Laboratories SWOT Analysis
2.3.4 Bio-Rad Laboratories Product and Services
2.3.5 Bio-Rad Laboratories Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.5 Perkinelmer
2.5.1 Perkinelmer Details
2.5.2 Perkinelmer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Perkinelmer SWOT Analysis
2.5.4 Perkinelmer Product and Services
2.5.5 Perkinelmer Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.6 GE Healthcare
2.6.1 GE Healthcare Details
2.6.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GE Healthcare SWOT Analysis
2.6.4 GE Healthcare Product and Services
2.6.5 GE Healthcare Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hemogenix
2.7.1 Hemogenix Details
2.7.2 Hemogenix Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hemogenix SWOT Analysis
2.7.4 Hemogenix Product and Services
2.7.5 Hemogenix Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Agilent Technologies SWOT Analysis
2.8.4 Agilent Technologies Product and Services
2.8.5 Agilent Technologies Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.9 Promega Corporation
2.9.1 Promega Corporation Details
2.9.2 Promega Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Promega Corporation SWOT Analysis
2.9.4 Promega Corporation Product and Services
2.9.5 Promega Corporation Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cell Biolabs
2.10.1 Cell Biolabs Details
2.10.2 Cell Biolabs Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Cell Biolabs SWOT Analysis
2.10.4 Cell Biolabs Product and Services
2.10.5 Cell Biolabs Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.11 Stemcell Technologies
2.11.1 Stemcell Technologies Details
2.11.2 Stemcell Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Stemcell Technologies SWOT Analysis
2.11.4 Stemcell Technologies Product and Services
2.11.5 Stemcell Technologies Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.12 Bio-Techne Corporation
2.12.1 Bio-Techne Corporation Details
2.12.2 Bio-Techne Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Bio-Techne Corporation SWOT Analysis
2.12.4 Bio-Techne Corporation Product and Services
2.12.5 Bio-Techne Corporation Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
2.13 Cellular Dynamics International (CDI)
2.13.1 Cellular Dynamics International (CDI) Details
2.13.2 Cellular Dynamics International (CDI) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Cellular Dynamics International (CDI) SWOT Analysis
2.13.4 Cellular Dynamics International (CDI) Product and Services
2.13.5 Cellular Dynamics International (CDI) Human Embryonic Stem Cell Assay Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Human Embryonic Stem Cell Assay Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Embryonic Stem Cell Assay Players Market Share
3.2.2 Top 10 Human Embryonic Stem Cell Assay Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Human Embryonic Stem Cell Assay Revenue and Market Share by Regions
4.2 North America Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
4.3 Europe Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
4.5 South America Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
5 North America Human Embryonic Stem Cell Assay Revenue by Countries
5.1 North America Human Embryonic Stem Cell Assay Revenue by Countries (2015-2020)
5.2 USA Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
5.3 Canada Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
5.4 Mexico Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
6 Europe Human Embryonic Stem Cell Assay Revenue by Countries
6.1 Europe Human Embryonic Stem Cell Assay Revenue by Countries (2015-2020)
6.2 Germany Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
6.3 UK Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
6.4 France Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
6.5 Russia Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
6.6 Italy Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Human Embryonic Stem Cell Assay Revenue by Countries
7.1 Asia-Pacific Human Embryonic Stem Cell Assay Revenue by Countries (2015-2020)
7.2 China Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
7.3 Japan Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
7.4 Korea Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
7.5 India Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
8 South America Human Embryonic Stem Cell Assay Revenue by Countries
8.1 South America Human Embryonic Stem Cell Assay Revenue by Countries (2015-2020)
8.2 Brazil Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
8.3 Argentina Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Human Embryonic Stem Cell Assay by Countries
9.1 Middle East & Africa Human Embryonic Stem Cell Assay Revenue by Countries (2015-2020)
9.2 Saudi Arabia Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
9.3 UAE Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
9.4 Egypt Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
9.5 South Africa Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Human Embryonic Stem Cell Assay Revenue and Market Share by Type (2015-2020)
10.2 Global Human Embryonic Stem Cell Assay Market Forecast by Type (2019-2024)
10.3 Viability/Cytotoxicity Revenue Growth Rate (2015-2025)
10.4 Isolation & Purification Revenue Growth Rate (2015-2025)
10.5 Cell Identification Revenue Growth Rate (2015-2025)
10.6 Proliferation Revenue Growth Rate (2015-2025)
10.7 Differentiation Revenue Growth Rate (2015-2025)
10.8 Function Revenue Growth Rate (2015-2025)
10.9 Apoptosis Revenue Growth Rate (2015-2025)
11 Global Human Embryonic Stem Cell Assay Market Segment by Application
11.1 Global Human Embryonic Stem Cell Assay Revenue Market Share by Application (2015-2020)
11.2 Human Embryonic Stem Cell Assay Market Forecast by Application (2019-2024)
11.3 Biopharmaceutical & Biotechnology Companies Revenue Growth (2015-2020)
11.4 Research Institutes Revenue Growth (2015-2020)
12 Global Human Embryonic Stem Cell Assay Market Size Forecast (2021-2025)
12.1 Global Human Embryonic Stem Cell Assay Market Size Forecast (2021-2025)
12.2 Global Human Embryonic Stem Cell Assay Market Forecast by Regions (2021-2025)
12.3 North America Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
12.4 Europe Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
12.6 South America Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Human Embryonic Stem Cell Assay Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Embryonic Stem Cell Assay by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Embryonic Stem Cell Assay Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Human Embryonic Stem Cell Assay Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 6. Thermo Fisher Scientific Human Embryonic Stem Cell Assay Major Business
Table 7. Thermo Fisher Scientific Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher Scientific SWOT Analysis
Table 9. Thermo Fisher Scientific Human Embryonic Stem Cell Assay Product and Solutions
Table 10. Thermo Fisher Scientific Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Miltenyi Biotec Corporate Information, Location and Competitors
Table 12. Miltenyi Biotec Human Embryonic Stem Cell Assay Major Business
Table 13. Miltenyi Biotec Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2018-2019)
Table 14. Miltenyi Biotec SWOT Analysis
Table 15. Miltenyi Biotec Human Embryonic Stem Cell Assay Product and Solutions
Table 16. Miltenyi Biotec Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 18. Bio-Rad Laboratories Human Embryonic Stem Cell Assay Major Business
Table 19. Bio-Rad Laboratories Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 20. Bio-Rad Laboratories SWOT Analysis
Table 21. Bio-Rad Laboratories Human Embryonic Stem Cell Assay Product and Solutions
Table 22. Bio-Rad Laboratories Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Corporate Information, Location and Competitors
Table 24. Merck Human Embryonic Stem Cell Assay Major Business
Table 25. Merck Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 26. Merck SWOT Analysis
Table 27. Merck Human Embryonic Stem Cell Assay Product and Solutions
Table 28. Merck Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Perkinelmer Corporate Information, Location and Competitors
Table 30. Perkinelmer Human Embryonic Stem Cell Assay Major Business
Table 31. Perkinelmer Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 32. Perkinelmer SWOT Analysis
Table 33. Perkinelmer Human Embryonic Stem Cell Assay Product and Solutions
Table 34. Perkinelmer Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GE Healthcare Corporate Information, Location and Competitors
Table 36. GE Healthcare Human Embryonic Stem Cell Assay Major Business
Table 37. GE Healthcare Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 38. GE Healthcare SWOT Analysis
Table 39. GE Healthcare Human Embryonic Stem Cell Assay Product and Solutions
Table 40. GE Healthcare Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Hemogenix Corporate Information, Location and Competitors
Table 42. Hemogenix Human Embryonic Stem Cell Assay Major Business
Table 43. Hemogenix Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 44. Hemogenix SWOT Analysis
Table 45. Hemogenix Human Embryonic Stem Cell Assay Product and Solutions
Table 46. Hemogenix Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Agilent Technologies Corporate Information, Location and Competitors
Table 48. Agilent Technologies Human Embryonic Stem Cell Assay Major Business
Table 49. Agilent Technologies Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 50. Agilent Technologies SWOT Analysis
Table 51. Agilent Technologies Human Embryonic Stem Cell Assay Product and Solutions
Table 52. Agilent Technologies Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Promega Corporation Corporate Information, Location and Competitors
Table 54. Promega Corporation Human Embryonic Stem Cell Assay Major Business
Table 55. Promega Corporation Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 56. Promega Corporation SWOT Analysis
Table 57. Promega Corporation Human Embryonic Stem Cell Assay Product and Solutions
Table 58. Promega Corporation Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Cell Biolabs Corporate Information, Location and Competitors
Table 60. Cell Biolabs Human Embryonic Stem Cell Assay Major Business
Table 61. Cell Biolabs Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 62. Cell Biolabs SWOT Analysis
Table 63. Cell Biolabs Human Embryonic Stem Cell Assay Product and Solutions
Table 64. Cell Biolabs Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Stemcell Technologies Corporate Information, Location and Competitors
Table 66. Stemcell Technologies Human Embryonic Stem Cell Assay Major Business
Table 67. Stemcell Technologies Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 68. Stemcell Technologies SWOT Analysis
Table 69. Stemcell Technologies Human Embryonic Stem Cell Assay Product and Solutions
Table 70. Stemcell Technologies Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Bio-Techne Corporation Corporate Information, Location and Competitors
Table 72. Bio-Techne Corporation Human Embryonic Stem Cell Assay Major Business
Table 73. Bio-Techne Corporation Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 74. Bio-Techne Corporation SWOT Analysis
Table 75. Bio-Techne Corporation Human Embryonic Stem Cell Assay Product and Solutions
Table 76. Bio-Techne Corporation Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Cellular Dynamics International (CDI) Corporate Information, Location and Competitors
Table 78. Cellular Dynamics International (CDI) Human Embryonic Stem Cell Assay Major Business
Table 79. Cellular Dynamics International (CDI) Human Embryonic Stem Cell Assay Total Revenue (USD Million) (2017-2018)
Table 80. Cellular Dynamics International (CDI) SWOT Analysis
Table 81. Cellular Dynamics International (CDI) Human Embryonic Stem Cell Assay Product and Solutions
Table 82. Cellular Dynamics International (CDI) Human Embryonic Stem Cell Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Human Embryonic Stem Cell Assay Revenue (Million USD) by Players (2015-2020)
Table 84. Global Human Embryonic Stem Cell Assay Revenue Share by Players (2015-2020)
Table 85. Global Human Embryonic Stem Cell Assay Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Human Embryonic Stem Cell Assay Revenue Market Share by Regions (2015-2020)
Table 87. North America Human Embryonic Stem Cell Assay Revenue by Countries (2015-2020)
Table 88. North America Human Embryonic Stem Cell Assay Revenue Market Share by Countries (2015-2020)
Table 89. Europe Human Embryonic Stem Cell Assay Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Human Embryonic Stem Cell Assay Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Human Embryonic Stem Cell Assay Revenue by Countries (2015-2020)
Table 92. South America Human Embryonic Stem Cell Assay Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Human Embryonic Stem Cell Assay Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Human Embryonic Stem Cell Assay Revenue Market Share by Countries (2015-2020)
Table 95. Global Human Embryonic Stem Cell Assay Revenue (Million USD) by Type (2015-2020)
Table 96. Global Human Embryonic Stem Cell Assay Revenue Share by Type (2015-2020)
Table 97. Global Human Embryonic Stem Cell Assay Revenue Forecast by Type (2021-2025)
Table 98. Global Human Embryonic Stem Cell Assay Revenue by Application (2015-2020)
Table 99. Global Human Embryonic Stem Cell Assay Revenue Share by Application (2015-2020)
Table 100. Global Human Embryonic Stem Cell Assay Revenue Forecast by Application (2021-2025)
Table 101. Global Human Embryonic Stem Cell Assay Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Human Embryonic Stem Cell Assay Picture
Figure 2. Global Human Embryonic Stem Cell Assay Revenue Market Share by Type in 2019
Figure 3. Viability/Cytotoxicity Picture
Figure 4. Isolation & Purification Picture
Figure 5. Cell Identification Picture
Figure 6. Proliferation Picture
Figure 7. Differentiation Picture
Figure 8. Function Picture
Figure 9. Apoptosis Picture
Figure 10. Human Embryonic Stem Cell Assay Revenue Market Share by Application in 2019
Figure 11. Biopharmaceutical & Biotechnology Companies Picture
Figure 12. Research Institutes Picture
Figure 13. Global Human Embryonic Stem Cell Assay Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Human Embryonic Stem Cell Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Human Embryonic Stem Cell Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Human Embryonic Stem Cell Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Human Embryonic Stem Cell Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Human Embryonic Stem Cell Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Human Embryonic Stem Cell Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Human Embryonic Stem Cell Assay Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Human Embryonic Stem Cell Assay Revenue Market Share in 2019
Figure 22. Global Top 10 Players Human Embryonic Stem Cell Assay Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Human Embryonic Stem Cell Assay Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Human Embryonic Stem Cell Assay Revenue Market Share by Regions (2015-2020)
Figure 26. Global Human Embryonic Stem Cell Assay Revenue Market Share by Regions in 2018
Figure 27. North America Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 28. Europe Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 30. South America Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 32. North America Human Embryonic Stem Cell Assay Revenue Market Share by Countries (2015-2020)
Figure 33. North America Human Embryonic Stem Cell Assay Revenue Market Share by Countries in 2019
Figure 34. USA Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 35. Canada Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 37. Europe Human Embryonic Stem Cell Assay Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Human Embryonic Stem Cell Assay Revenue Market Share by Countries in 2019
Figure 39. Germany Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 40. UK Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 41. France Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 42. Russia Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 43. Italy Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Human Embryonic Stem Cell Assay Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Human Embryonic Stem Cell Assay Revenue Market Share by Countries in 2019
Figure 46. China Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 47. Japan Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 48. Korea Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 49. India Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 51. South America Human Embryonic Stem Cell Assay Revenue Market Share by Countries (2015-2020)
Figure 52. South America Human Embryonic Stem Cell Assay Revenue Market Share by Countries in 2019
Figure 53. Brazil Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Human Embryonic Stem Cell Assay Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Human Embryonic Stem Cell Assay Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 58. UAE Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Human Embryonic Stem Cell Assay Revenue and Growth Rate (2015-2020)
Figure 61. Global Human Embryonic Stem Cell Assay Revenue Share by Type (2015-2020)
Figure 62. Global Human Embryonic Stem Cell Assay Revenue Share by Type in 2019
Figure 63. Global Human Embryonic Stem Cell Assay Market Share Forecast by Type (2021-2025)
Figure 64. Global Viability/Cytotoxicity Revenue Growth Rate (2015-2020)
Figure 65. Global Isolation & Purification Revenue Growth Rate (2015-2020)
Figure 66. Global Cell Identification Revenue Growth Rate (2015-2020)
Figure 67. Global Proliferation Revenue Growth Rate (2015-2020)
Figure 68. Global Differentiation Revenue Growth Rate (2015-2020)
Figure 69. Global Function Revenue Growth Rate (2015-2020)
Figure 70. Global Apoptosis Revenue Growth Rate (2015-2020)
Figure 71. Global Human Embryonic Stem Cell Assay Revenue Share by Application (2015-2020)
Figure 72. Global Human Embryonic Stem Cell Assay Revenue Share by Application in 2019
Figure 73. Global Human Embryonic Stem Cell Assay Market Share Forecast by Application (2021-2025)
Figure 74. Global Biopharmaceutical & Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 75. Global Research Institutes Revenue Growth Rate (2015-2020)
Figure 76. Global Human Embryonic Stem Cell Assay Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Human Embryonic Stem Cell Assay Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Human Embryonic Stem Cell Assay Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
Figure 80. Europe Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
Figure 82. South America Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Human Embryonic Stem Cell Assay Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
ヒト胚性幹細胞アッセイの世界市場（～2026年） Market Analysis and Insights: Global Human Embryonic Stem Cell Assay Market The global Human Embryonic Stem Cell Assay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Embryonic Stem Cell Assay Scope and Market Si…- 幹細胞アッセイの世界市場（～2026年） The demand of global stem cell assay is increasing. Market Analysis and Insights: Global Stem Cell Assay Market The global Stem Cell Assay market size is projected to reach US$ 843 million by 2026, from US$ 750.5 million in 2020, at a CAGR of 11.4%% during 2021-2026. Global Stem Cell Assay Scope and…
- 成体幹細胞アッセイの世界市場（～2026年） Market Analysis and Insights: Global Adult Stem Cell Assay Market The global Adult Stem Cell Assay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adult Stem Cell Assay Scope and Market Size Adult Stem Cell Assay marke…
- 幹細胞アッセイの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Stem Cell Assay market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9% in the forecast period of 2020 to 2025 and will expected to reach USD 1168.3 million by 2025, from USD 772.2 million in 2019. The Stem Cell Assay mark…
- ヒト間葉系幹細胞（hMSC）の世界市場（～2026年） Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types. Market Analysis and Insights: Global Human Mesenchymal Stem Cells (hMSC) Market The global Human Mesenchymal Stem Cells (hMSC) market size is projected to reach US$ XX million by 20…